
Alok Khorana, MD
@aakonc
Followers
5K
Following
45K
Media
605
Statuses
10K
Hardis Endowed Chair, FACP, FASCO, Prof Med, Vice Chair Taussig Cancer Ctr, Dir GI Cancers, @ClevelandClinic. Writer. Opinions my own. I have #FCOI.
Cleveland, Ohio
Joined December 2011
My new piece on @DalrympleWill's Golden Road, which releases this week in the US- A Deeply Globalized Ancient World.via @lithub.
lithub.com
It was my first visit to Tokyo. Thanks to a lost-in-translation miscommunication with my scientific colleagues, I found myself with an unexpectedly open daytime schedule. This is how I ended up alo…
2
9
33
RT @EnriqueSoto8: Thrilled to share our new ASCO Global Guideline on Geriatric Assessment 🌍👵👴 — supporting cancer care for older adults in….
0
48
0
RT @MadisonConces: Excited and grateful for this opportunity! The study will open later this year and evaluate trifluridine/tipiracil plus….
0
5
0
"The way we write and talk about disability matters" via @lithub.
lithub.com
Like many writers, I have been following the unfolding revelations about Raynor Winn and The Salt Path with great interest, and a degree of self-interest. I am a memoirist and nature writer, and I …
1
0
2
RT @smitha42: Thrilled to be here at the #WalkToEndColonCancer with patients/ families/friends/colleagues in beautiful CLE raising 💰for #C….
0
10
0
RT @DavidLiskaMD: Great turnout today #WalkToEndColonCancer! Proud of our @ClevelandClinic colorectal surgery and #WeissCenter teams showin….
0
18
0
RT @tmprowell: #MedTwitter #OncTwitter. Action Item: If you enjoy being able to see your doctor via #telehealth, call your representatives….
0
47
0
RT @MarcCarrier1: Radiotherapy is essential in cancer care, but evidence shows it may independently raise the risk of VTE. 🩸⚡ . This review….
0
12
0
Super interesting vaccine ph I data (mix of pancreatic and CRC).
The final results from @ElicioTx AMPLIFY trial are in @NatureMedicine reinforcing what has been seen with other platforms - a robust T cell response to tumor antigens post-vaccine is associated with delayed #PancreaticCancer recurrence after surgery.
0
0
1
RT @AnthonyrSloan: We are happy to highlight a new preprint on @biorxivpreprint where we reveal a sex-specific estrogen dependent role for….
biorxiv.org
Sex differences in cancer outcomes, including glioblastoma (GBM), are shaped by biological, hormonal, and immune factors, influencing disease progression, treatment responses, survival, and the tumor...
0
3
0
Optimizing diet/exercise post treatment is becoming more and more important. Need to figure out models to operationalize this @DavidLiskaMD.@smitha42."being physically active & diet rich in vegetables fruits, whole grains after stage III colon cancer assoc w/ a longer survival".
Read the Original Investigation “Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis.”
1
8
27
"45-49 years:.- CRC screening prevalence increased from 20.8% in to 33.7% in 2023.- colonoscopy prevalence increased from 19.5% in 2019 to 27.7% in 2023.- stool-based testing increased from 1.3% in 2019 to 7.1% in 2023".
jamanetwork.com
This study evaluates changes in colorectal cancer screening uptake among adults aged 45 to 49 years.
0
3
12
RT @Erman_Akkus: 🟠1L treatments of advanced pancreatic cancer.➡️mFOLFIRINOX or S-IROX vs Gem-nab-paclitaxel.GENERATE, JCOG1611 @JCO_ASCO….
0
42
0
RT @Dr_ElvinaA: HIMALAYA is the 1st phase III trial to show 5-year OS in unresectable HCC!.regular Durva/single Tremelimumab (Stride) 5-yr….
0
43
0
RT @jamecancerdoc: Please join me in Congratulating @paolocaimiMD recipient of Excellence in research award and Dr. Christy Samaras recipie….
0
6
0
RT @beatalleukemia: 👇🏾 Incredibly harmful for our cancer patients who rely on novel clinical trials with new drugs that can be potentially….
0
9
0
RT @weldeiry: The R01 Grant pay-line is at the 4th %-ile at @theNCI (4 out of 100 reviewed grants will be awarded this year). “expect to fu….
cancer.gov
NCI funding policy for research project grant (RPG) awards reflects the funding goals of the institute, NIH, and HHS.
0
7
0
Good news for step counters: 7K steps are nearly as good as 10K; associated w/ "substantially lower risks for all-cause mortality, cardiovascular disease incidence, cancer mortality, dementia, and depressive symptoms.
thelancet.com
Although 10 000 steps per day can still be a viable target for those who are more active, 7000 steps per day is associated with clinically meaningful improvements in health outcomes and might be a...
1
1
7